By crystallizing human CHCHD4’s AIF-interaction domain with an activated AIF dimer, we uncover how NADH allosterically configures AIF to anchor CHCHD4’s β-hairpin and histidine-helix motifs to the ...

2月5日，精工钢构跌0.34%，成交额6097.17万元，换手率1.03%，总市值58.98亿元。 根据AI大模型测算精工钢构后市走势。短期趋势看，连续2日被主力资金增仓。主力没有控盘。中期趋势方面，上方有一定套牢筹码积压。近期该股有吸筹现象，但吸筹力度不强。舆情分析来看，3家机构预测目标均价2.94，高于当前价0.34%。目前市场情绪极度悲观。 异动分析 装配式建筑+雄安新区+新型城镇化+NMN ...

Department of Pharmaceutical Engg.Tech, IIT-Banaras Hindu University,Varanasi, Uttar Pradesh 221005, India ...

Zerodha founder and chief executive Nithin Kamath tells Deepsekhar Choudhury that the philosophy of a company is what sets it ...

PNN New Delhi [India] February 1 New Delhi is set to host a historic convergence of creatives innovators policymakers and start-ups as What Design Can Do WDCD presents its first-ever South Asian editi ...

1月18日，由HELEVATED主办的「悦梦长寿私享沙龙」在深圳联想后海中心成功举办。

DeepSeek-R1, a powerful open-source LLM, challenges the notion of high costs for AI development. This shift, along with the ...

研究人员开发的 AMT 技术，利用修饰的脂肪细胞靶向癌症代谢途径，在多种癌症模型中显著抑制肿瘤生长，减少肿瘤的糖酵解、脂肪酸代谢和尿苷利用，改善缺氧和血管生成情况。脂肪细胞作为一种独特的体外治疗系统，具有诸多优势，如临床获取和移植技术成熟，可通过 CRISPRa 技术进行基因调控，还能与多种癌症治疗方法联合使用。

Indian startups are yet to deliver breakthroughs in the global GenAI race because all service offerings are wrappers around large language models (LLMs), equally available to everyone, said Zerodha ...

Ohio State University has described NADH-ubiquinone oxidoreductase (complex I) inhibitors acting as radiosensitizers for radiation therapy reported to be useful for the treatment of cancer.

DRY January will soon be over for those observing it – but while millions will enjoy a celebratory drink, it is also worth ...

It was founded by Nitin Kamath, co-founder of Zerodha. Kailash Nadh, the CTO of Zerodha is also a co-founder of Rainmatter. In 2024, Rainmatter invested ₹275 crore in 47 startups, and it plans to ...